ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Immune Regulation teams with DynPort on COVID-19 drug pharmatimes
July 07, 2020US and UK-based clinical stage biotech Immune Regulation has signed a deal with DynPort Vaccine Company to jointly evaluate the potential of the former's ILR201104 to treat COVID-19 related Acute Respiratory Distress Syndrome (ARDS) in US clinical trials.
Pharma Sources Insight January 2025
